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Introduction: Patients receiving chronic anticoagulation for a mechanical heart valve (MHV) often require temporary interruption of warfarin for 
an invasive procedure. The relative efficacy and safety of hospitalization and intravenous unfractionated heparin (IVUH) vs. outpatient low molecular 
weight heparin (LMWH) “bridging” as peri-procedural anticoagulation management is unknown.
Methods:  In a retrospective population-based case-cohort study, Olmsted County, MN residents with MHV who received outpatient peri-procedural 
LMWH management (cases) over the 7-year period, 1997-2003 (n=149), were matched on valve and procedure type to MHV residents who received 
inpatient IVUH peri-procedural management (cohort) over the same timeframe. Both groups were followed forward in time through their complete 
medical records in the community for TE and major bleeding within 3 months.
Results:  149 cases (100 aortic, 29 mitral, 20 both; 64% bileaflet) were compared to 149 cohort members (100 aortic, 29 mitral, 20 both; 75% 
bileaflet). While the 3-month cumulative incidence of TE did not differ significantly among cases (2.7%) and cohort members (cohort 4.7%; p=0.36), 
major bleeding was significantly lower in cases (5.4% vs. 15.4%; p<0.005). 
Conclusions:  For MHV patients requiring interruption of chronic anticoagulation for an invasive diagnostic or therapeutic procedure, outpatient 
LWMH peri-procedural management is as effective as inpatient IVUH management and is associated with less major bleeding.
